Request Demo
Last update 19 Mar 2026
Diclofenac/Tramadol
Last update 19 Mar 2026
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors, agonists |
Mechanism COX inhibitors(Cyclooxygenases inhibitors), μ opioid receptor agonists(Mu opioid receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC16H26ClNO2 |
InChIKeyPPKXEPBICJTCRU-NDFJEYLFSA-N |
CAS Registry36282-47-0 |
View All Structures (2)
Related
2
Clinical Trials associated with Diclofenac/TramadolNCT03714672
A Randomized, Double-blind, Multi-site, Comparator-controlled, Phase III Trial to Evaluate the Efficacy and Safety of a Fixed-dose Combination of Tramadol Hydrochloride and Diclofenac Sodium in Acute Moderate to Severe Pain After Third Molar Extraction
IRCT2014070718392N1
Comparison of the effect of Intravenous tramadol with Dexamethasone and tramadol with diclofenac on acute post-operative pain after cesarean surgery
100 Clinical Results associated with Diclofenac/Tramadol
Login to view more data
100 Translational Medicine associated with Diclofenac/Tramadol
Login to view more data
100 Patents (Medical) associated with Diclofenac/Tramadol
Login to view more data
100 Deals associated with Diclofenac/Tramadol
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Pain | Phase 3 | Mexico | 26 Aug 2017 | |
| Pain | Phase 3 | - | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 3 | 1,151 | (Tramadol/Diclofenac 50/50) | wajibjlomh(asgchxuwoq) = jxsmlprrvi jpzpbqvpmk (bjiovacrid, tyjmyxkjnw - ipbhiorttv) View more | - | 24 Jul 2019 | ||
(Tramadol/Diclofenac 25/25) | wajibjlomh(asgchxuwoq) = iswdygfpmr jpzpbqvpmk (bjiovacrid, zjxgfbojku - obbgqkwmek) View more | ||||||
Phase 3 | 52 | gcramkxsbt(ffcitxtzfl) = nausea, vomiting, epigastric pain, gastritis jkvleqxesz (fjjucndmjh ) | Positive | 17 Apr 2015 | |||
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free